Trial intelligence / Profile preview

HCV eradication model using Epclusa in irregular immigrants and low-income refugees in southern Italy

2017-001024-21Phase 4Completed

Sponsor
University of Campania Luigi Vanvitelli
Start
Oct 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of velpatasvir in hepatitis C virus infection, sponsored by University of Campania Luigi Vanvitelli. Started Oct 2021; status: completed.

02

Drugs

velpatasvir
03

Conditions

hepatitis C virus infection

Beyond the preview

Go deeper on 2017-001024-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-001024-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call